Type:Notice
Citation:90 FR 9735
Reading Time:about a minute or two
Lonza Tampa, LLC has applied to the Drug Enforcement Administration to become registered as an importer of controlled substances, specifically focusing on the drug code 7437 (Psilocybin). They plan to use Psilocybin as a bulk active pharmaceutical ingredient for clinical trials, research, and analytical purposes. The DEA is allowing registered bulk manufacturers or applicants to submit electronic comments or objections to this application by March 20, 2025. Requests for a hearing can also be submitted by this date.
Simple Explanation
Lonza Tampa, LLC wants permission from the government to bring in a special kind of drug called psilocybin for science experiments and tests, and people can tell the government what they think about this until March 20, 2025.